ha15 (TargetMol)
Structured Review

Ha15, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha15/product/TargetMol
Average 94 stars, based on 1 article reviews
Images
1) Product Images from "Hypoxia-induced GRP78 activation disrupts the Fndc5/Irisin axis to accelerate skeletal muscle atrophy"
Article Title: Hypoxia-induced GRP78 activation disrupts the Fndc5/Irisin axis to accelerate skeletal muscle atrophy
Journal: Cell Stress & Chaperones
doi: 10.1016/j.cstres.2026.100176
Figure Legend Snippet: Effects of HA15 on C2C12 myoblast viability, GRP78 and Fndc5/irisin expression, and myotube formation. (a) CCK-8 assay showing the viability of C2C12 myoblasts treated with different concentrations of HA15 (1, 5, 10, 50, and 100 µM). Data are presented as mean ± SD ( n = 6), with significant differences indicated ( P < 0.05). (b) Western blot analysis of GRP78 and Fndc5/irisin protein levels in C2C12 myoblasts after treatment with HA15 at the indicated concentrations. β-Tubulin is used as a loading control. (c) Quantification of GRP78 protein expression normalized to β-Tubulin from the Western blot. Data are presented as mean ± SD ( n = 3), with significant differences indicated ( P < 0.001). (d) Immunofluorescence staining showing the expression of MyHC (green) and nuclear staining with Hoechst (blue) in C2C12 myotubes treated with various concentrations of HA15 (1 µM, 5 µM, 10 µM, 50 µM, and 100 µM). (e) Quantification of the myotube fusion index, data presented as mean ± SD ( n = 3). (f) Quantification of myotube diameter, data presented as mean ± SD ( n = 3). (g) Quantification of myotube area, data presented as mean ± SD ( n = 3). Significant differences are indicated by P values.
Techniques Used: Expressing, CCK-8 Assay, Western Blot, Control, Immunofluorescence, Staining


